Of these, four studies [20–23] found no significant differences in TNFα production capacity and inflammatory complications (e.g. SIRS, sepsis and pneumonia), whereas one study [24] reported a significantly lower percentage of monocytes expressing TNFα in patients who developed inflammatory complications compared to patients who did not. This evidence concerns the gene TNF and susceptibility to pneumonia measurement.